OsmonDRBerbariEFBerendtAR, et al; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56:e1-e25. doi:10.1093/cid/cis803
PooleGStradlingPWorlledgeS.Potentially serious side effects of high-dose twice-weekly rifampicin. Br Med J. 1971;3:343-347.
4.
A controlled trial of daily and intermittent rifampicin and ethambutol in retreatment of patients with pulmonary tuberculosis: results up to 30 months. Tubercle. 1975;56:179-189.
5.
BlajchmanMALowryRCPettitJEStradlingP.Rifampicin-induced immune thrombocytopenia. Br Med J. 1970;3:24-26.
6.
LeggatPO.Rifampicin and thrombocytopenia. Lancet. 1971;2:103-104.
7.
MoriMIzawaKFujikawaT, et al. A case of acute and severe thrombocytopenia due to readministration of rifampicin. J Infect Chemother. 2011;17:288-290. doi:10.1007/s10156-010-0117-x
8.
NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
